WO2010149794A3 - Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) - Google Patents
Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) Download PDFInfo
- Publication number
- WO2010149794A3 WO2010149794A3 PCT/EP2010/059149 EP2010059149W WO2010149794A3 WO 2010149794 A3 WO2010149794 A3 WO 2010149794A3 EP 2010059149 W EP2010059149 W EP 2010059149W WO 2010149794 A3 WO2010149794 A3 WO 2010149794A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- allylamin
- hydroxypropane
- diallyl
- diamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
Abstract
A solid, pharmaceutical composition for oral administration comprising from about 80% to about 94% by weight of sevelamer including the water of hydration and at least one pharmaceutically acceptable excipient.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930368 | 2009-06-26 | ||
ES200930368A ES2350999B1 (en) | 2009-06-26 | 2009-06-26 | NEW PHARMACEUTICAL COMPOSITION UNDERSTANDING POLY HYDROCHLORIDE (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-PROPANE HYDROXY). |
EPPCT/EP2009/058122 | 2009-06-29 | ||
PCT/EP2009/058122 WO2010149230A1 (en) | 2009-06-26 | 2009-06-29 | Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride |
ARP20100102272 | 2010-06-25 | ||
ARP100102272A AR077244A1 (en) | 2009-06-26 | 2010-06-25 | PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE) |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010149794A2 WO2010149794A2 (en) | 2010-12-29 |
WO2010149794A3 true WO2010149794A3 (en) | 2011-06-16 |
Family
ID=43386953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/059149 WO2010149794A2 (en) | 2009-06-26 | 2010-06-28 | Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010149794A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103159881A (en) * | 2011-12-14 | 2013-06-19 | 上海亿法医药科技有限公司 | Preparation method for sevelamer hydrochloride |
CN103159880B (en) * | 2011-12-14 | 2016-06-22 | 上海亿法医药科技有限公司 | The preparation method of 2-Propen-1-amine polymer with(chloromethyl)oxirane carbonate |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2545907A1 (en) * | 2011-07-15 | 2013-01-16 | Combino Pharm, S.L. | Aqueous wet granulation process for cross-linked polyallylamine polymers |
CN111773190A (en) * | 2020-06-24 | 2020-10-16 | 北京瑞迪道森医药科技有限公司 | Sevelamer carbonate tablet for improving safety of preparation and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001028527A2 (en) * | 1999-10-19 | 2001-04-26 | Geltex Pharmaceuticals, Inc. | Direct compression polymer tablet core |
WO2007094779A1 (en) * | 2006-02-14 | 2007-08-23 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
WO2008062437A2 (en) * | 2006-09-01 | 2008-05-29 | Usv Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
WO2009034540A1 (en) * | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Pharmaceutical composition of sevelamer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
-
2010
- 2010-06-28 WO PCT/EP2010/059149 patent/WO2010149794A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001028527A2 (en) * | 1999-10-19 | 2001-04-26 | Geltex Pharmaceuticals, Inc. | Direct compression polymer tablet core |
WO2007094779A1 (en) * | 2006-02-14 | 2007-08-23 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
WO2008062437A2 (en) * | 2006-09-01 | 2008-05-29 | Usv Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
WO2009034540A1 (en) * | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Pharmaceutical composition of sevelamer |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103159881A (en) * | 2011-12-14 | 2013-06-19 | 上海亿法医药科技有限公司 | Preparation method for sevelamer hydrochloride |
CN103159881B (en) * | 2011-12-14 | 2016-04-27 | 上海亿法医药科技有限公司 | The preparation method of sevelamer hydrochloride |
CN103159880B (en) * | 2011-12-14 | 2016-06-22 | 上海亿法医药科技有限公司 | The preparation method of 2-Propen-1-amine polymer with(chloromethyl)oxirane carbonate |
Also Published As
Publication number | Publication date |
---|---|
WO2010149794A2 (en) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012000369A (en) | Tamper-resistant dosage form for oxidation-sensitive oploids. | |
WO2010146179A3 (en) | Solid pharmaceutical composition comprising rivaroxaban | |
WO2010084115A3 (en) | Antiviral agents | |
WO2011012322A3 (en) | Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms | |
EP3626253A3 (en) | Stable formulations of linaclotide | |
WO2008012622A3 (en) | Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor | |
WO2008122965A3 (en) | Pharmaceutical cyclosporin compositions | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2008154083A3 (en) | Compounds, compositions and methods for the treatment of synucleinopathies | |
WO2011110939A3 (en) | Pharmaceutical compositions of substituted benzhydrylpiperazines | |
UA105766C2 (en) | Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin | |
WO2009081174A3 (en) | Anti - retroviral combination | |
WO2012075362A3 (en) | Chemokine cxcr4 receptor modulators and used related thereto | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2012087255A3 (en) | Pharmaceutical formulations comprising imatinib | |
JP2009537554A5 (en) | ||
MX2013000474A (en) | Novel arylamide derivatives having antiandrogenic properties. | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
BRPI1009392A2 (en) | "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation." | |
EP2241310A3 (en) | Modified release formulations of emoxypine | |
TN2011000651A1 (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application | |
EP2384746A3 (en) | Dual release oral tablet compositions of dexlansoprazole | |
WO2010046933A3 (en) | Pharmaceutical compositions of taste-masked linezolid | |
WO2010012459A3 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10730415 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10730415 Country of ref document: EP Kind code of ref document: A2 |